iCardio.ai closes $4.5M strategic financing led by Cedars-Sinai Technology Ventures.
The round expands our proprietary data foundation more than fivefold — granting unprecedented access to Cedars-Sinai's institutional cardiac imaging dataset across TTE, TEE, cardiac MR/CT, ECG, and longitudinal outcomes. It builds on the momentum of two FDA clearances applying AI to echocardiography, with several additional regulatory filings pending.
"We are at one of the great inflection points in the history of medicine." — Dr. Harlan KrumholzRead the announcement on LinkedIn ↗